DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE

 

PUBLIC HEALTH SERVICE . BETHESDA 14, MD.

 

NATIONAL INSTITUTES OF HEALTH

JAN 2 1 1959

Dear Mr. Fogarty:

The Surgeon General, Dr. Burney, has asked me to reply to
your letter of January 10 with which you forwarded a copy of a
letter from Mr. John M, Davis to Mr. Francis A. Mooney of Pawtucket,
Rhode Island, and other attachments concerning Krebiozen.

The National Cancer Institute has not heretofore participated
in any testing of Krebiozen and has no direct knowledge of its possible
usefulness in the treatment of cancer. However, two medical groups
who examined clinical data on the use of the agent have published
their findings. These groups were a subcommittee of the Committee
on Research, Council on Pharmacy and Chemistry of the American Medical
Association, and the Committee on Cancer Diagnosis and Therapy of the
National Research Council. Neither found evidence from the data
examined that Krebiozen was an effective treatment for cancer.

The National Cancer Institute is now in communication with
Dr, Andrew C. Ivy, consultant to the Krebiozen Research Foundation,
with reference to a proposed evaluation of the agent by the Institute.
A committee of experts is being selected to study data supplied by
Dr. Ivy, and advise as to whether further investigation should be
undertaken and how it should proceed. Dr. Ivy, at a meeting on
December 5 promised to set forth in writing what he considered his
role in relation to the evaluating committee should be. We have not
heard from Dr. Ivy since the December 5 meeting.

In my letter to you dated January 1) in reference to another
letter from Mr. Davis, I explained in more detail the developments
concerning Krebiozen. There are no new developments, and I trust
that this information will meet your needs.

Sincerely yours,

ak Heller, M. D.
ve Director
\-“" National Cancer Institute

Hon. John E, Fogarty
House of Representatives
Washington 25, D.C.

National Cancer Institute National Heart Institute National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Metabolic Diseases
National Institute of Dental Research National Institute of Mental Health National Institute of Neurological Diseases and Blindness The Clinical Center
Division of Biologics Standards Division of Business Operations Division of Research Grants Division of Research Services